Akinsanya Karen 4
4 · Nautilus Biotechnology, Inc. · Filed Jun 17, 2024
Insider Transaction Report
Form 4
Akinsanya Karen
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-14+45,000→ 45,000 totalExercise: $2.56Exp: 2034-06-14→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month).